The neurological assessment in young children treated with artesunate monotherapy or artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria

Malaria Journal

Volumn 8, Issue 1, 2009, Pages

  Ambler, Michael T ^a   Dubowitz, Lilly M ^a,b   Arunjerdja, Ratree ^a   Hla, Eh Paw ^a   Thwai, Kyaw Lay ^a   Viladpainguen, Jacher ^a   Singhasivanon, Pratap ^c   Luxemburger, Christine ^a   Nosten, François ^a,c,d   McGready, Rose ^a,c,d  

^a SHOKLO MALARIA RESEARCH UNIT   (Thailand)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c MAHIDOL UNIVERSITY   (Thailand)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTESUNATE; MEFLOQUINE; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE;

ARTICLE; BEHAVIOR DISORDER; CHILD; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; MONOTHERAPY; MOTOR COORDINATION; MOTOR DYSFUNCTION; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; ANIMAL; ASIA; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DRUG COMBINATION; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; SOUTHEAST ASIA;

ANIMALS; ANTIMALARIALS; ARTEMISININS; ASIA; ASIA, SOUTHEASTERN; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INFANT; MALARIA, FALCIPARUM; MALE; MEFLOQUINE; NERVOUS SYSTEM DISEASES; NEUROLOGIC EXAMINATION;

EID: 70349237044     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-8-207     Document Type: Article

References (45)

1. WHO guidelines for the treatment of malaria. WHO, Geneva: World Health Organization 2006 http://www.who.int/malaria/docs/TreatmentGuidelines2006.pdf
2. Consensus recommendation on the treatment of malaria in Southeast Asia. S Looareesuwan P Olliaro NJ White T Chongsuphajaisiddhi A Sabcharoen K Thimasarn F Nosten P Singhasivanon S Supavej S Khusmith S Wylings T Kanyok D Walsh PA Leggat EB Doberstyn, Southeast Asian Journal of Tropical Medicine and Public Health 1998 29 355 360 9886127
3. Plasmodium falciparum antimalarial drug susceptibility on the north-western border of Thailand during five years of extensive use of artesunate-mefloquine. A Brockman RN Price M van Vugt DG Heppner D Walsh P Sookto T Wimonwattrawatee S Looareesuwan NJ White F Nosten, Trans R Soc Trop Med Hyg 2000 94 537 544 10.1016/S0035-9203(00)90080-4 11132385
4. New antimalarials. A risk-benefit analysis. F Nosten RN Price, Drug Saf 1995 12 264 273 10.2165/00002018-199512040-00006 7646825
5. Artemisinin-based combination treatment of falciparum malaria. F Nosten NJ White, Am J Trop Med Hyg 2007 77 181 192 18165491
6. Artesunate/mefloquine treatment of multi-drug resistant falciparum malaria. RN Price F Nosten C Luxemburger M van Vugt L Phaipun T Chongsuphajaisiddhi NJ White, Trans R Soc Trop Med Hyg 1997 91 574 577 10.1016/S0035-9203(97)90032-8 9463672
7. Safety of artemisinin and its derivatives. A review of published and unpublished clinical trials. IR Ribeiro P Olliaro, Med Trop (Mars) 1998 58 50 53 10212898
8. Neuropsychiatric Adverse Effects of Mefloquine: What Do We Know and What Should We Do? F Nosten M van Vugt, CNS Drugs 1999 11 1 8 10.2165/00023210- 199911010-00001 (Pubitemid 29065798)
9. CNS adverse events associated with antimalarial agents. Fact or fiction? PA Phillips-Howard FO ter Kuile, Drug Saf 1995 12 370 383 10.2165/00002018- 199512060-00003 8527012
10. Neuropsychiatric events and travel: do antimalarials play a role? P Schlagenhauf R Steffen, J Travel Med 2000 7 225 226 11231204
11. Antimalarial drug toxicity: a review. WR Taylor NJ White, Drug Saf 2004 27 25 61 10.2165/00002018-200427010-00003 14720085
12. Review of the central nervous system adverse effects related to the antimalarial drug, mefloquine. WHO, Organization WH. Geneva 1991
13. Tolerability of prophylactic Lariam regimens. E Boudreau B Schuster J Sanchez W Novakowski R Johnson D Redmond R Hanson L Dausel, Trop Med Parasitol 1993 44 257 265 8256107
14. Tolerance of mefloquine by SwissAir trainee pilots. P Schlagenhauf H Lobel R Steffen R Johnson K Popp A Tschopp R Letz C Crevoisier, Am J Trop Med Hyg 1997 56 235 240 9080886
15. Effects of mefloquine alone and with alcohol on psychomotor and driving performance. EF Vuurman ND Muntjewerff MM Uiterwijk LM van Veggel C Crevoisier L Haglund M Kinzig JF O'Hanlon, Eur J Clin Pharmacol 1996 50 475 482 10.1007/s002280050144 8858275
16. Mefloquine prophylaxisProphylaxis and hearing, postural controlHearing, Postural Control, and vestibular functionsVestibular Functions. AC Hessen-Soderman J Bergenius IB Palme Y Bergqvist U Hellgren, J Travel Med 1995 2 66 69 10.1111/j.1708-8305.1995.tb00629.x 9815364
17. Tolerance of mefloquine chemoprophylaxis in Dutch military personnel. CA Jaspers AP Hopperus Buma PP van Thiel RA van Hulst PA Kager, Am J Trop Med Hyg 1996 55 230 234 8780466
18. Mefloquine in infants and young children. C Luxemburger RN Price F Nosten FO Ter Kuile T Chongsuphajaisiddhi NJ White, Ann Trop Paediatr 1996 16 281 286 8985524
19. Clinical studies on the treatment of malaria with qinghaosu and its derivatives. China Cooperative Research Group on qinghaosu and its derivatives as antimalarials. J Tradit Chin Med 1982 2 45 50 6765847
20. Studies on the toxicity of qinghaosu and its derivatives. China Cooperative Research Group on qinghaosu and its derivatives as antimalarials. J Tradit Chin Med 1982 2 31 38 6765846
21. The chemistry, pharmacology, and clinical applications of qinghaosu (artemisinin) and its derivatives. XD Luo CC Shen, Med Res Rev 1987 7 29 52 10.1002/med.2610070103 3550324
22. Fatal neurotoxicity of arteether and artemether. TG Brewer SJ Grate JO Peggins PJ Weina JM Petras BS Levine MH Heiffer BG Schuster, Am J Trop Med Hyg 1994 51 251 259 7943542
23. Behavioral and neural toxicity of arteether in rats. RF Genovese DB Newman JM Petras TG Brewer, Pharmacol Biochem Behav 1998 60 449 458 10.1016/S0091-3057(98)00019-7 9632228
24. Arteether-induced brain injury in Macaca mulatta. I. The precerebellar nuclei: the lateral reticular nuclei, paramedian reticular nuclei, and perihypoglossal nuclei. JM Petras GD Young RA Bauman DE Kyle M Gettayacamin HK Webster KD Corcoran JO Peggins MA Vane TG Brewer, Anat Embryol (Berl) 2000 201 383 397 10.1007/s004290050326 10839633
25. Adverse effects in patients with acute falciparum malaria treated with artemisinin derivatives. R Price M van Vugt L Phaipun C Luxemburger J Simpson R McGready F ter Kuile A Kham T Chongsuphajaisiddhi NJ White F Nosten, Am J Trop Med Hyg 1999 60 547 555 10348227
26. Clinical and neurophysiological study of the effects of multiple doses of artemisinin on brain-stem function in Vietnamese patients. E Kissinger TT Hien NT Hung ND Nam NL Tuyen BV Dinh C Mann NH Phu PP Loc JA Simpson NJ White JJ Farrar, Am J Trop Med Hyg 2000 63 48 55 11357994
27. A case-control auditory evaluation of patients treated with artemisinin derivatives for multidrug-resistant Plasmodium falciparum malaria. M Van Vugt BJ Angus RN Price C Mann JA Simpson C Poletto SE Htoo S Looareesuwan NJ White F Nosten, Am J Trop Med Hyg 2000 62 65 69 10761725
28. Auditory assessment of patients with acute uncomplicated Plasmodium falciparum malaria treated with three-day mefloquine-artesunate on the north-western border of Thailand. VI Carrara AP Phyo P Nwee M Soe H Htoo J Arunkamomkiri P Singhasivanon F Nosten, Malar J 2008 7 233 10.1186/1475-2875-7- 233 18986553
29. Neuropathological assessment of artemether-treated severe malaria. TT Hien GD Turner NT Mai NH Phu D Bethell WF Blakemore JB Cavanagh A Dayan I Medana RO Weller NP Day NJ White, Lancet 2003 362 295 296 10.1016/S0140-6736(03)13974- 8 12892962
30. Severe and complicated malaria. World Health Organization, Division of Control of Tropical Diseases. Trans R Soc Trop Med Hyg 1990 84 Suppl 2 1 65
31. Mefloquine pharmacokinetics and resistance in children with acute falciparum malaria. F Nosten F ter Kuile T Chongsuphajaisiddhi K Na Bangchang J Karbwang NJ White, Br J Clin Pharmacol 1991 31 556 559 1888626
32. The abilities of babies. R Griffiths, London: University of London Press 1954
33. Movement assessment battery for children. SE Henderson DA Sugden, London: Harcourt Brace 1992
34. Optimality score for the neurologic examination of the infant at 12 and 18 months of age. L Haataja E Mercuri R Regev F Cowan M Rutherford V Dubowitz L Dubowitz, J Pediatr 1999 135 153 161 10.1016/S0022-3476(99)70016-8 10431108
35. The Bayley Scales of Infant Development. N Bayley, New York: Harcourt/Psychological Corporation 2 1993
36. A new approach for neurological evaluation of infants in resource-poor settings. L Haataja R McGready R Arunjerdja JA Simpson E Mercuri F Nosten L Dubowitz, Ann Trop Paediatr 2002 22 355 368 10.1179/027249302125002029 12530286
37. Predictors of mefloquine treatment failure: a prospective study of 1590 patients with uncomplicated falciparum malaria. F ter Kuile C Luxemburger F Nosten KL Thwai T Chongsuphajaisiddhi NJ White, Transactions of the Royal Society of Tropical Medicine and Hygiene 1995 89 660 664 10.1016/0035-9203(95) 90435-2 8594690 (Pubitemid 26016357)
38. Assessing developmental outcomes in children from Kilifi, Kenya, following prophylaxis for seizures in cerebral malaria. A Abubakar FJ Van De Vijver S Mithwani E Obiero N Lewa S Kenga K Katana P Holding, J Health Psychol 2007 12 417 430 10.1177/1359105307076230 17439993
39. Describing the burden of malaria on child development: what should we be measuring and how should we be measuring it? PA Holding PK Kitsao-Wekulo, Am J Trop Med Hyg 2004 71 71 79 15331821
40. Impact of asymptomatic malaria parasitaemia on cognitive function and school achievement of schoolchildren in the Yemen Republic. AW Al Serouri SM Grantham-McGregor B Greenwood A Costello, Parasitology 2000 121 Pt 4 337 345 10.1017/S0031182099006502 11072896
41. Effects of early cerebral malaria on cognitive ability in Senegalese children. MJ Boivin, J Dev Behav Pediatr 2002 23 353 364 12394524
42. Cognitive sequelae of severe malaria with impaired consciousness. PA Holding J Stevenson N Peshu K Marsh, Trans R Soc Trop Med Hyg 1999 93 529 534 10.1016/S0035-9203(99)90368-1 10696414
43. Absence of neuropsychological sequelae following cerebral malaria in Gambian children. AH Muntendam S Jaffar N Bleichrodt MB van Hensbroek, Trans R Soc Trop Med Hyg 1996 90 391 394 10.1016/S0035-9203(96)90518-0 8882184
44. Febrile infants at low risk for serious bacterial infection - an appraisal of the Rochester criteria and implications for management. Febrile Infant Collaborative Study Group. JA Jaskiewicz CA McCarthy AC Richardson KC White DJ Fisher R Dagan KR Powell, Pediatrics 1994 94 390 396 8065869
45. Risk factors for persisting neurological and cognitive impairments following cerebral malaria. R Idro JA Carter G Fegan BG Neville CR Newton, Arch Dis Child 2006 91 142 148 10.1136/adc.2005.077784 16326798